Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
Meeting ReportCardiovascular Track

Initial clinical validation of respiratory motion-corrected myocardial viability PET and simultaneous coronary MR angiography

Camila Munoz, Karl Kunze, Radhouene Neji, Teresa Vitadello, Christoph Rischpler, Rene Botnar, Claudia Prieto and Stephan Nekolla
Journal of Nuclear Medicine May 2018, 59 (supplement 1) 231;
Camila Munoz
1Imaging Sciences Division King's College London London United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karl Kunze
3Technische Universitaet Muenchen Muenchen Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Radhouene Neji
1Imaging Sciences Division King's College London London United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Teresa Vitadello
4Nuklearmedizin TU Muenchen Nuklearmedizin Muenchen Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christoph Rischpler
2Dept. of Nuclear Medicine Technical University Munich Munich Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rene Botnar
1Imaging Sciences Division King's College London London United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claudia Prieto
1Imaging Sciences Division King's College London London United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephan Nekolla
4Nuklearmedizin TU Muenchen Nuklearmedizin Muenchen Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

231

Introduction: Cardiac PET-MR has shown promising results for the comprehensive assessment of coronary artery disease [1]. A recently proposed framework for simultaneous motion corrected PET/MR imaging allows the visualisation of myocardial metabolic integrity by 18F-FDG PET and coronary lumen integrity by Coronary Magnetic Resonance Angiography (CMRA) in a single efficient examination [2]. Here we present an initial clinical validation of this method in a cohort of patients with known cardiovascular disease.

Methods: The proposed method consists in an ECG-triggered free-breathing sequence simultaneously acquired with list-mode cardiac PET data. Respiratory motion is estimated from MR images and used to correct the MR data while simultaneously providing non-rigid motion fields for MR-based PET respiratory motion correction for both the emission data and attenuation maps. Fourteen patients (66.1±9.5 years) with chronic total occlusion (CTO) of at least one coronary artery were scanned on a Biograph mMR scanner (Siemens Healthcare). Clinical PET-MR imaging included a 40 to 50 min insulin-clamped 18F-FDG list-mode PET acquisition, the proposed PET-CMRA framework [2], and a 2D-PSIR Late Gadolinium Enhancement (LGE) acquisition. CMRA and PET data were reconstructed with the proposed motion correction scheme (MC) [2] and without motion correction (NMC). PET image reconstruction was performed offline using reconstruct-transform-average [3] motion correction in Siemens e7 Tools (OSEM, 3 iterations, 21 subsets, PSF modelling, 2.03x2.08x2.08mm voxel size, 127x344x344 matrix size). RESULTS: Average acquisition time for the proposed PET-CMRA acquisition was 11.2±2.4 minutes. Two patients were excluded as there was no overlap between the PET and the MR acquisition, and one patient for was not being able to receive Gadolinium-based contrast agent. MR images were reformatted to simultaneously visualize the left and right coronary arteries. MC MR images showed sufficient quality for depicting the proximal coronary anatomy (Fig1a), which was in agreement with X-ray angiography (not shown). For PET images, motion correction improved visualisation of small structures as well as delineation of myocardial defects (Fig1b). The degree of transmurality of viability defects was better depicted in MC PET images and an improved agreement with the LGE was observed. Integral tracer in the LV myocardium as quantified with a volumetric analysis, increased significantly especially in inferior and lateral regions after motion correction, indicating improved signal recovery of myocardial tracer uptake.

Conclusions: We have presented the clinical validation of a novel respiratory motion-corrected cardiac PET-MR framework for simultaneous visualization of coronary anatomy and myocardial integrity in patients with coronary artery disease. Motion corrected 18F-FDG PET images were in good agreement with LGE-MRI and show a more accurate depiction of both transmural and non-transmural viability defects. REFERENCES: [1] Rischpler C et al. Hybrid PET/MR imaging of the heart: potential, initial experiences, and future prospects. J Nucl Med 2013;54:402-415.[2] Munoz C et al. Motion-corrected simultaneous cardiac positron emission tomography and coronary MR angiography with high acquisition efficiency. Magn Reson Med 2017. doi: 10.1002/mrm.26690[3] Picard Y et al. Motion correction of PET images using multiple acquisition frames. IEEE Trans Med Imaging 1997;16:137-144.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 59, Issue supplement 1
May 1, 2018
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Initial clinical validation of respiratory motion-corrected myocardial viability PET and simultaneous coronary MR angiography
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Initial clinical validation of respiratory motion-corrected myocardial viability PET and simultaneous coronary MR angiography
Camila Munoz, Karl Kunze, Radhouene Neji, Teresa Vitadello, Christoph Rischpler, Rene Botnar, Claudia Prieto, Stephan Nekolla
Journal of Nuclear Medicine May 2018, 59 (supplement 1) 231;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Initial clinical validation of respiratory motion-corrected myocardial viability PET and simultaneous coronary MR angiography
Camila Munoz, Karl Kunze, Radhouene Neji, Teresa Vitadello, Christoph Rischpler, Rene Botnar, Claudia Prieto, Stephan Nekolla
Journal of Nuclear Medicine May 2018, 59 (supplement 1) 231;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Cardiovascular Track

  • To Evaluated the Cardiac Function of Patients with Acute Myocardial Infarction by the Volume and Filling Curve of 99mTc-MIBI SPECT Myocardial Perfusion Imaging
  • Standard versus low-dose rubidium-82 dynamic positron emission tomography imaging with scanner-dependent bias correction for myocardial perfusion imaging and blood flow quantification
  • Evaluation of sympathetic function with PET 11C-hydroxyephedrine (HED) and ammonia (13N-NH3) in a canine pacing model of atrial fibrillation
Show more Cardiovascular Track

Cardiac Metabolism, Viability, and Innervation

  • Evaluation of sympathetic function with PET 11C-hydroxyephedrine (HED) and ammonia (13N-NH3) in a canine pacing model of atrial fibrillation
  • Clinical significance of quantitative assessment of right ventricular glucose metabolism in patients with heart failure with reduced ejection fraction
  • Evaluation of Cardiac Sympathetic Denervation using 18F-FDOPA PET-CT in Idiopathic Parkinson Disease
Show more Cardiac Metabolism, Viability, and Innervation

Similar Articles

SNMMI

© 2022 Journal of Nuclear Medicine

Powered by HighWire